BIO-RAD LABORATORIES INC.

Company Snapshot

Founded: 1952
Entity Type: Public
Employees: 7,450
Region: U.S.
Revenue: $2,583.2 Millions
Revenue Year: 2025
Segment: Life Sciences and Clinical Diagnostics
Headquarter: California, U.S.
Key Geographics: U.S., Europe, Asia, Canada, Latin America
Corporate Address: 1000 Alfred Nobel Drive, Hercules, California, 94547 U.S. Tel. +1-510-724-7000 www.bio-rad.com

Company Overview

Bio-Rad Laboratories develops biochemical and radiochemical products. It designs and manufactures a range of diagnostic tools and services for research institutions, hospitals, pharmaceutical and biotechnology companies, and academic institutions. It operates in two business segments: life science and clinical diagnostics. The life sciences category's equipment, systems, reagents, and consumables are used to characterize, quantify, segregate, and purify biological components such as proteins, cells, and nucleic acids.

Bio-Rad's technologies find applications in analyzing biomolecules (antibodies, proteins, nucleic acids, cells, bacteria). Technologies include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, protein function analysis, transfection, flow cytometry, cell sorting, amplification and real-time and digital PCR.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BIO-RAD LABORATORIES INC. In Reports

Global HLA Typing for Transplant Market

Analyze the global HLA typing for transplant market, covering technologies, applications, key players and growth forecasts across regions to 2030.

Bioinformatics: Technologies and Global Markets

BCC Research detailed research report on bioinformatics technology market revenue ($ million) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030.

Cancer Profiling and Pathways: Technologies and Global Markets

According to BCC Research detailed report on Cancer Profiling and Pathways Technologies Market using 2024 as the base year, 2025 as the estimate year and CAGR projections for the period 2025-2030.

Company's Business Segments

  • Life Sciences : It offers instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids
  • Clinical Diagnostics : It includes diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories
  • Others : Miscellaneous operations

Applications/End User Industries

  • Academic and Research Institutions
  • Universities
  • Research Centers
  • Academic Laboratories
  • Biotechnology
  • Blood Banks and Transfusion Centers
  • Regulatory Agencies
  • Public Health Organizations
  • Contract Research Organizations
  • Clinical Laboratories
  • Medical Laboratories
  • Diagnostic Centers
  • Physician Office Laboratories
  • Pharmaceuticals
AI Sentiment